These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9758310

  • 21. Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).
    Bacigalupo A, Oneto R, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Romagnani C, Bruno B, Van Lint MT, Frassoni F.
    Bone Marrow Transplant; 2001 Dec; 28(12):1093-6. PubMed ID: 11803348
    [Abstract] [Full Text] [Related]

  • 22. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
    Schleuning M, Günther W, Tischer J, Ledderose G, Kolb HJ.
    Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
    [Abstract] [Full Text] [Related]

  • 23. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS, Engemann AM, Hammond JM.
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y.
    Transplantation; 2003 Jun 27; 75(12):2135-43. PubMed ID: 12829926
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept.
    Wolff D, Roessler V, Steiner B, Wilhelm S, Weirich V, Brenmoehl J, Leithaeuser M, Hofmeister N, Junghanss C, Casper J, Hartung G, Holler E, Freund M.
    Bone Marrow Transplant; 2005 May 27; 35(10):1003-10. PubMed ID: 15806135
    [Abstract] [Full Text] [Related]

  • 28. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY, Kwok J, Lie AK, Chen P, Chen FE, Liang R.
    Haematologica; 2001 Jun 27; 86(6):652-6. PubMed ID: 11418376
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
    Hervé P, Racadot E, Wijdenes J, Flesch M, Tiberghien P, Bordigoni P, Holler E, Powles M, Bourdeau M, Wilmer E.
    Bone Marrow Transplant; 1991 Jun 27; 7 Suppl 2():149. PubMed ID: 1878688
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevention and treatment of acute GvHD--new modalities.
    Hervé P.
    Nouv Rev Fr Hematol (1978); 1993 Jun 27; 35(3):295-7. PubMed ID: 8337146
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.
    Anasetti C, Martin PJ, Hansen JA, Appelbaum FR, Beatty PG, Doney K, Harkonen S, Jackson A, Reichert T, Stewart P.
    Transplantation; 1990 Jul 27; 50(1):49-54. PubMed ID: 2368150
    [Abstract] [Full Text] [Related]

  • 37. [Efficacy of anti-CD25 monoclonal antibody used in treating steroid-resistant acute graft-versus-host disease following haploidentical bone marrow transplantation].
    Liu J, Wang HX, Duan LN, Yang HM, Xue M, Zhu L, Ding L, Wang ZD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb 27; 17(1):160-3. PubMed ID: 19236770
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.